352 related articles for article (PubMed ID: 38534381)
1. Protein Stability Regulation in Osteosarcoma: The Ubiquitin-like Modifications and Glycosylation as Mediators of Tumor Growth and as Targets for Therapy.
Di Gregorio J; Di Giuseppe L; Terreri S; Rossi M; Battafarano G; Pagliarosi O; Flati V; Del Fattore A
Cells; 2024 Mar; 13(6):. PubMed ID: 38534381
[TBL] [Abstract][Full Text] [Related]
2. SUMOylation and NEDDylation in Primary and Metastatic Cancers to Bone.
Gomarasca M; Lombardi G; Maroni P
Front Cell Dev Biol; 2022; 10():889002. PubMed ID: 35465332
[TBL] [Abstract][Full Text] [Related]
3. The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer.
Pellegrino NE; Guven A; Gray K; Shah P; Kasture G; Nastke MD; Thakurta A; Gesta S; Vishnudas VK; Narain NR; Kiebish MA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408841
[TBL] [Abstract][Full Text] [Related]
4. Insights in Post-Translational Modifications: Ubiquitin and SUMO.
Salas-Lloret D; González-Prieto R
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328702
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-specific proteases as therapeutic targets in paediatric primary bone tumours?
Mullard M; Lavaud M; Regnier L; Tesfaye R; Ory B; Rédini F; Verrecchia F
Biochem Pharmacol; 2021 Dec; 194():114797. PubMed ID: 34678225
[TBL] [Abstract][Full Text] [Related]
6. Silencing Ubc9 expression suppresses osteosarcoma tumorigenesis and enhances chemosensitivity to HSV-TK/GCV by regulating connexin 43 SUMOylation.
Zhang D; Yu K; Yang Z; Li Y; Ma X; Bian X; Liu F; Li L; Liu X; Wu W
Int J Oncol; 2018 Sep; 53(3):1323-1331. PubMed ID: 29956745
[TBL] [Abstract][Full Text] [Related]
7. MLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcoma.
Zhang Y; Shi CC; Zhang HP; Li GQ; Li SS
Oncotarget; 2016 Jul; 7(29):45263-45274. PubMed ID: 27223074
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-Like Post-Translational Modifications (Ubl-PTMs): Small Peptides with Huge Impact in Liver Fibrosis.
Lachiondo-Ortega S; Mercado-Gómez M; Serrano-Maciá M; Lopitz-Otsoa F; Salas-Villalobos TB; Varela-Rey M; Delgado TC; Martínez-Chantar ML
Cells; 2019 Dec; 8(12):. PubMed ID: 31817258
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619.
Lavaud M; Mullard M; Tesfaye R; Amiaud J; Legrand M; Danieau G; Brion R; Morice S; Regnier L; Dupuy M; Brounais-Le Royer B; Lamoureux F; Ory B; Rédini F; Verrecchia F
Cells; 2021 Aug; 10(9):. PubMed ID: 34571917
[TBL] [Abstract][Full Text] [Related]
10. Acute Myeloid Leukemia-Related Proteins Modified by Ubiquitin and Ubiquitin-like Proteins.
Park SS; Baek KH
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008940
[TBL] [Abstract][Full Text] [Related]
11. [Ubiquitins, proteasomes, sumoylation and application today and in future for cancer and other diseases therapy II. Sumoylation and neddylation as posttranslational modifications of proteins and their ubiquitinylation and its significance].
Fuchs O; Neuwirtová R
Vnitr Lek; 2006 Jun; 52(6):619-27. PubMed ID: 16871767
[TBL] [Abstract][Full Text] [Related]
12. The involvement of post-translational modifications in cardiovascular pathologies: Focus on SUMOylation, neddylation, succinylation, and prenylation.
Gao J; Shao K; Chen X; Li Z; Liu Z; Yu Z; Aung LHH; Wang Y; Li P
J Mol Cell Cardiol; 2020 Jan; 138():49-58. PubMed ID: 31751566
[TBL] [Abstract][Full Text] [Related]
13. Rlim, an E3 ubiquitin ligase, influences the stability of Stathmin protein in human osteosarcoma cells.
Chen X; Shen J; Li X; Wang X; Long M; Lin F; Wei J; Yang L; Yang C; Dong K; Zhang H
Cell Signal; 2014 Jul; 26(7):1532-8. PubMed ID: 24686088
[TBL] [Abstract][Full Text] [Related]
14. Post-translational modifications inducing proteasomal degradation to counter HIV-1 infection.
Proulx J; Borgmann K; Park IW
Virus Res; 2020 Nov; 289():198142. PubMed ID: 32882242
[TBL] [Abstract][Full Text] [Related]
15. PTEN in osteosarcoma: Recent advances and the therapeutic potential.
Zheng C; Tang F; Min L; Hornicek F; Duan Z; Tu C
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188405. PubMed ID: 32827577
[TBL] [Abstract][Full Text] [Related]
16. CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma.
Zhang T; Li J; Yang M; Ma X; Wang Z; Ma X; Sun M; Sun W; Xu J; Hua Y; Cai Z
Oncogene; 2022 Sep; 41(40):4524-4536. PubMed ID: 36042349
[TBL] [Abstract][Full Text] [Related]
17. Posttranslational modifications of proteins in the pathobiology of medically relevant fungi.
Leach MD; Brown AJ
Eukaryot Cell; 2012 Feb; 11(2):98-108. PubMed ID: 22158711
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Ubiquitin-Proteasome System and Recent Advances in Cancer Therapy.
Spano D; Catara G
Cells; 2023 Dec; 13(1):. PubMed ID: 38201233
[TBL] [Abstract][Full Text] [Related]
19. G-protein-coupled estrogen receptor suppresses the migration of osteosarcoma cells via post-translational regulation of Snail.
Wang Z; Chen X; Zhao Y; Jin Y; Zheng J
J Cancer Res Clin Oncol; 2019 Jan; 145(1):87-96. PubMed ID: 30341688
[TBL] [Abstract][Full Text] [Related]
20. NEDDylation regulates E2F-1-dependent transcription.
Loftus SJ; Liu G; Carr SM; Munro S; La Thangue NB
EMBO Rep; 2012 Sep; 13(9):811-8. PubMed ID: 22836579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
